Evidence map›Paper›PMID 39791603›Full record

ArticleBlood2025

Cullin-5 controls the number of megakaryocyte-committed stem cells to prevent thrombocytosis in mice.

Maria Kauppi, Craig D Hyland, Elizabeth M Viney, Christine A White, Carolyn A de Graaf, AnneMarie E Welch, Jumana Yousef, Laura F Dagley, Samantha J Emery-Corbin, Ladina Di Rago and 7 more

Abstract read
In one paragraph

Article in Blood, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Maria KauppiBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.ORCID 0000-0002-6022-9910
Craig D HylandBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.ORCID 0000-0002-0079-8986
Elizabeth M VineyBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Christine A WhiteBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Carolyn A de GraafBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.ORCID 0000-0001-8380-5311
AnneMarie E WelchBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.ORCID 0000-0002-6103-340X
Jumana YousefDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.ORCID 0000-0002-2364-6299
Laura F DagleyDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.ORCID 0000-0003-4171-3712
Samantha J Emery-CorbinDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.ORCID 0000-0003-2984-0620
Ladina Di RagoImmunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Andrew J KuehBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Marco J HeroldBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.ORCID 0000-0001-7539-7581
Douglas J HiltonBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Jeffrey J BabonDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.
Nicos A NicolaBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Kira BehrensBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.ORCID 0000-0003-0800-8472
Warren S AlexanderBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractCullin-5 (Cul5) coordinates the assembly of cullin-RING-E3 ubiquitin ligase complexes that include the suppressors of cytokine signaling (SOCS)-box-containing proteins. The SOCS-box proteins function to recruit specific substrates to the complex for ubiquitination and degradation. In hematopoiesis, SOCS-box proteins are best known for regulating the actions of cytokines that utilize the JAK-STAT signaling pathway. However, the roles of most SOCS-box proteins have not been studied in physiological contexts and any actions for Cul5/SOCS complexes in signaling by several hematopoietic cytokines, including thrombopoietin (TPO) and interleukin-3 (IL-3), remain unknown. To define additional potential roles for Cul5/SOCS complexes, we generated mice lacking Cul5 in hematopoiesis; the absence of Cul5 is predicted to impair the SOCS-box-dependent actions of all proteins that contain this motif. Here, we show that Cul5-deficient mice develop excess megakaryopoiesis and thrombocytosis revealing a novel mechanism of negative regulation of megakaryocyte-committed stem cells, a distinct population within the hematopoietic stem cell pool that have been shown to rapidly, perhaps directly, generate megakaryocytes, and which are produced in excess in the absence of Cul5. Cul5-deficient megakaryopoiesis is distinctive in being largely independent of TPO/myeloproliferative leukemia protein and involves signaling via the β-common and/or β-IL-3 receptors, with evidence of deregulated responses to IL-3. This process is independent of the interferon-α/β receptor, previously implicated in inflammation-induced activation of stem-like megakaryocyte progenitor cells.

Indexed as

Cullin ProteinsMegakaryocyte Progenitor CellsMegakaryocytesThrombocytosisAnimalsMiceMice, Inbred C57BLMice, KnockoutSignal TransductionSuppressor of Cytokine Signaling ProteinsThrombopoiesisThrombopoietincullin5 protein, mouseCullin ProteinsSuppressor of Cytokine Signaling ProteinsThrombopoietin

Identifiers

PMID39791603
PMCPMC11923429

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.